Della Torre P - Search Results

1

PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential.

Della Torre P, Podestà A, Imondi AR, Moneta D, Sammartini U, Arrigoni C, Terron A, Brughera M. Della Torre P, et al. Cancer Chemother Pharmacol. 2001 Apr;47(4):355-60. doi: 10.1007/s002800000240. Cancer Chemother Pharmacol. 2001. PMID: 11345653

2

Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxane.

Della Torre P, Mazué G, Podestà A, Moneta D, Sammartini U, Imondi AR. Della Torre P, et al. Cancer Chemother Pharmacol. 1999;43(2):151-6. doi: 10.1007/s002800050876. Cancer Chemother Pharmacol. 1999. PMID: 9923821

3

Cardioprotection by dexrazoxane in rats treated with doxorubicin and paclitaxel.

Della Torre P, Imondi AR, Bernardi C, Podestà A, Moneta D, Riflettuto M, Mazué G. Della Torre P, et al. Cancer Chemother Pharmacol. 1999;44(2):138-42. doi: 10.1007/s002800050958. Cancer Chemother Pharmacol. 1999. PMID: 10412948

4

Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent.

Geroni C, Ripamonti M, Arrigoni C, Fiorentini F, Capolongo L, Moneta D, Marchini S, Della Torre P, Albanese C, Lamparelli MG, Ciomei M, Rossi R, Caruso M. Geroni C, et al. Among authors: della torre p. Cancer Res. 2001 Mar 1;61(5):1983-90. Cancer Res. 2001. PMID: 11280756

5

Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.

Imondi AR, Della Torre P, Mazué G, Sullivan TM, Robbins TL, Hagerman LM, Podestà A, Pinciroli G. Imondi AR, et al. Among authors: della torre p. Cancer Res. 1996 Sep 15;56(18):4200-4. Cancer Res. 1996. PMID: 8797592

6

Evaluation of 4'-iodo-4'-deoxydoxorubicin-induced cardiotoxicity in two experimental rat models.

Podestà A, Della Torre P, Pinciroli G, Iatropoulos MJ, Brughera M, Mazué G. Podestà A, et al. Among authors: della torre p. Toxicol Pathol. 1994 Jan-Feb;22(1):68-71. doi: 10.1177/019262339402200109. Toxicol Pathol. 1994. PMID: 8073224

7

Long-lasting effect of dexrazoxane against anthracycline cardiotoxicity in rats.

Della Torre P, Podesta A, Pinciroli G, Iatropoulos MJ, Mazué G. Della Torre P, et al. Toxicol Pathol. 1996 Jul-Aug;24(4):398-402. doi: 10.1177/019262339602400402. Toxicol Pathol. 1996. PMID: 8864181

8

Anthracyclines - a review of general and special toxicity studies.

Mazue G, Iatropoulos M, Imondi A, Castellino S, Brughera M, Podesta A, Dellatorre P, Moneta D. Mazue G, et al. Int J Oncol. 1995 Oct;7(4):713-26. Int J Oncol. 1995. PMID: 21552894

9

Investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) using the Frog Embryo Teratogenesis Assay-Xenopus (FETAX).

Longo M, Zanoncelli S, Della Torre P, Rosa F, Giusti A, Colombo P, Brughera M, Mazué G, Olliaro P. Longo M, et al. Among authors: della torre p. Reprod Toxicol. 2008 Aug;25(4):433-41. doi: 10.1016/j.reprotox.2008.02.004. Epub 2008 Feb 29. Reprod Toxicol. 2008. PMID: 18394862

10

Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529.

Agen C, Bernardini N, Danesi R, Della Torre P, Costa M, Del Tacca M. Agen C, et al. Among authors: della torre p. Cancer Chemother Pharmacol. 1992;30(2):95-9. doi: 10.1007/BF00686399. Cancer Chemother Pharmacol. 1992. PMID: 1600601

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters